Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 2521 AL 2535

Unzipping the Secrets of Amyloid Disassembly by the Human Disaggregase

Franco A, Velasco-Carneros L, Alvarez N, Orozco N, Moro F, Prado A, Muga A.

Cells. 2021 Oct 14;10(10):2745. doi: 10.3390/cells10102745.

Cochlear Inflammaging in Relation to Ion Channels and Mitochondrial Functions

Bazard P, Pineros J, Frisina RD, Bauer MA, Acosta AA, Paganella LR, Borakiewicz D, Thivierge M, Mannering FL, Zhu X, Ding B.

Cells. 2021 Oct 15;10(10):2761. doi: 10.3390/cells10102761.

North American survey on impact of the COVID-19 pandemic shutdown on DBS care

Siddiqui MS, Jimenez-Shahed J, Mari Z, Walter BL, De Jesus S, Panov F, Schwalb JM, York MK, Sarva H, Bertoni JM, Patel N, Zhang L, McInerney J, Rosenow JM.

Parkinsonism Relat Disord. 2021 Nov;92:41-45. doi: 10.1016/j.parkreldis.2021.10.011. Epub 2021 Oct 18.

The effects of treadmill exercise in animal models of Parkinson's disease: A systematic review

Ferreira AFF, Binda KH, Real CC.

Neurosci Biobehav Rev. 2021 Dec;131:1056-1075. doi: 10.1016/j.neubiorev.2021.10.019. Epub 2021 Oct 21.

Histamine H3 and H4 receptors modulate Parkinson's disease induced brain pathology. Neuroprotective effects of nanowired BF-2649 and clobenpropit with anti-histamine-antibody therapy

Sharma A, Muresanu DF, Patnaik R, Menon PK, Tian ZR, Sahib S, Castellani RJ, Nozari A, Lafuente JV, Buzoianu AD, Skaper SD, Bryukhovetskiy I, Manzhulo I, Wiklund L, Sharma HS.

Prog Brain Res. 2021;266:1-73. doi: 10.1016/bs.pbr.2021.06.003. Epub 2021 Oct 6.

A Review of miRNAs as Biomarkers and Effect of Dietary Modulation in Obesity Associated Cognitive Decline and Neurodegenerative Disorders

Perdoncin M, Konrad A, Wyner JR, Lohana S, Pillai SS, Pereira DG, Lakhani HV, Sodhi K.

Front Mol Neurosci. 2021 Oct 7;14:756499. doi: 10.3389/fnmol.2021.756499. eCollection 2021.

Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson's Disease

Li Y, Xia Y, Yin S, Wan F, Hu J, Kou L, Sun Y, Wu J, Zhou Q, Huang J, Xiong N, Wang T.

Front Immunol. 2021 Oct 8;12:719807. doi: 10.3389/fimmu.2021.719807. eCollection 2021.

Fahr syndrome - an incidental finding in a patient with lymphocytic meningitis

Okrzeja J, Narejko K, Tarasów E, Zajkowska J, Garkowski A.

Radiol Case Rep. 2021 Oct 11;16(12):3855-3858. doi: 10.1016/j.radcr.2021.09.025. eCollection 2021 Dec.

Rhabdomyolysis Associated with Severe Levodopa-Induced Dyskinesia in Parkinson's Disease: A Report of Two Cases and Literature Review

Pitakpatapee Y, Srikajon J, Sangpeamsook T, Srivanitchapoom P.

Tremor Other Hyperkinet Mov (N Y). 2021 Sep 30;11:39. doi: 10.5334/tohm.641. eCollection 2021.

Long-term Risk of Parkinson Disease Following Influenza and Other Infections

Cocoros NM, Svensson E, Szépligeti SK, Vestergaard SV, Szentkúti P, Thomsen RW, Borghammer P, Sørensen HT, Henderson VW.

JAMA Neurol. 2021 Dec 1;78(12):1461-1470. doi: 10.1001/jamaneurol.2021.3895.

Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medications

Antonini A, Odin P, Schmidt P, Cubillos F, Standaert DG, Henriksen T, Jimenez-Shahed J, Alobaidi A, Jalundhwala YJ, Bao Y, Zamudio J, Parra JC, Kukreja P, Onuk K, Skalicky AM, Kleinman L, Jones E, Metz S, Fernandez HH.

Parkinsonism Relat Disord. 2021 Nov;92:59-66. doi: 10.1016/j.parkreldis.2021.10.009. Epub 2021 Oct 13.

The Potential Role of COVID-19 in the Pathogenesis of Multiple Sclerosis-A Preliminary Report

Satheesh NJ, Salloum-Asfar S, Abdulla SA.

Viruses. 2021 Oct 17;13(10):2091. doi: 10.3390/v13102091.

Education on palliative care for Parkinson patients: development of the "Best care for people with late-stage Parkinson's disease" curriculum toolkit

Gatsios D, Antonini A, Gentile G, Konitsiotis S, Fotiadis D, Nixina I, Taba P, Weck C, Lorenzl S, Lex KM, Paal P.

BMC Med Educ. 2021 Oct 25;21(1):538. doi: 10.1186/s12909-021-02964-6.

Are ion channels potential therapeutic targets for Parkinson's disease?

Daniel NH, Aravind A, Thakur P.

Neurotoxicology. 2021 Dec;87:243-257. doi: 10.1016/j.neuro.2021.10.008. Epub 2021 Oct 23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias